Yarvitan

RSS

Withdrawn

This medicine's authorisation has been withdrawn

mitratapide
MedicineVeterinaryWithdrawn
  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for this product has been withdrawn at the request of the marketing authorisation holder.

español (ES) (256.72 KB - PDF)

View

čeština (CS) (393.52 KB - PDF)

View

dansk (DA) (256.17 KB - PDF)

View

Deutsch (DE) (257.38 KB - PDF)

View

eesti (ET) (255.5 KB - PDF)

View

ελληνικά (EL) (454.41 KB - PDF)

View

français (FR) (257.52 KB - PDF)

View

italiano (IT) (256.43 KB - PDF)

View

latviešu (LV) (399.71 KB - PDF)

View

lietuvių (LT) (373.07 KB - PDF)

View

magyar (HU) (384.35 KB - PDF)

View

Nederlands (NL) (256.77 KB - PDF)

View

polski (PL) (403.94 KB - PDF)

View

português (PT) (257.16 KB - PDF)

View

slovenčina (SK) (389.05 KB - PDF)

View

slovenščina (SL) (380.7 KB - PDF)

View

suomi (FI) (255.8 KB - PDF)

View

svenska (SV) (256.06 KB - PDF)

View

Product information

български (BG) (876.69 KB - PDF)

View

español (ES) (368.06 KB - PDF)

View

čeština (CS) (682.61 KB - PDF)

View

dansk (DA) (413.04 KB - PDF)

View

Deutsch (DE) (363.22 KB - PDF)

View

eesti (ET) (360.22 KB - PDF)

View

ελληνικά (EL) (926.55 KB - PDF)

View

français (FR) (369.55 KB - PDF)

View

italiano (IT) (358.34 KB - PDF)

View

latviešu (LV) (723.79 KB - PDF)

View

lietuvių (LT) (500.34 KB - PDF)

View

magyar (HU) (667.24 KB - PDF)

View

Malti (MT) (707.97 KB - PDF)

View

Nederlands (NL) (359.17 KB - PDF)

View

polski (PL) (707.86 KB - PDF)

View

português (PT) (369.01 KB - PDF)

View

română (RO) (511.36 KB - PDF)

View

slovenčina (SK) (679.07 KB - PDF)

View

slovenščina (SL) (667.27 KB - PDF)

View

suomi (FI) (355.26 KB - PDF)

View

svenska (SV) (366.58 KB - PDF)

View

български (BG) (312.24 KB - PDF)

View

español (ES) (232.03 KB - PDF)

View

čeština (CS) (307.25 KB - PDF)

View

dansk (DA) (233.01 KB - PDF)

View

Deutsch (DE) (235.26 KB - PDF)

View

eesti (ET) (231.11 KB - PDF)

View

ελληνικά (EL) (308.87 KB - PDF)

View

français (FR) (231.59 KB - PDF)

View

italiano (IT) (231.31 KB - PDF)

View

latviešu (LV) (309.08 KB - PDF)

View

lietuvių (LT) (262.26 KB - PDF)

View

magyar (HU) (304.77 KB - PDF)

View

Malti (MT) (309.64 KB - PDF)

View

Nederlands (NL) (234.5 KB - PDF)

View

polski (PL) (274.42 KB - PDF)

View

português (PT) (231.94 KB - PDF)

View

română (RO) (295.75 KB - PDF)

View

slovenčina (SK) (306.51 KB - PDF)

View

slovenščina (SL) (304.86 KB - PDF)

View

suomi (FI) (231.26 KB - PDF)

View

svenska (SV) (231.79 KB - PDF)

View

Product details

Name of medicine
Yarvitan
Active substance
mitratapide
International non-proprietary name (INN) or common name
mitratapide

Pharmacotherapeutic group

Antiobesity preparations, excl. diet products

Authorisation details

EMA product number
EMEA/V/C/000113

Assessment history

This page was last updated on

Share this page